← Back to Search

Nutritional Supplements for Joint Replacement Recovery

N/A
Recruiting
Led By Ran Schwarzkopf
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient are current candidates for elective primary total hip and total knee arthroplasty
Patients ≥55 years of age but ≤ 95
Must not have
Previous history of septic arthritis
End stage renal and hepatic disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 2 (2 wks pre) visit 3 (surgery day) visit 5 (4 weeks post)
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at whether giving extra nutrients to patients who are deficient in them can help improve recovery following joint replacement surgery.

Who is the study for?
This trial is for people aged 55 to 95 who are about to have hip or knee replacement surgery and show signs of poor nutrition (low levels of certain proteins in their blood). It's not for those with revision surgeries, protein absorption issues, eating disorders, past septic arthritis, severe kidney/liver disease, allergies to oral supplements, or can't take them by mouth.
What is being tested?
The study tests if a nutritional drink called Ensure can improve blood markers related to nutrition in patients who don't get enough nutrients and are having joint replacement surgery.
What are the potential side effects?
Ensure is generally safe but may cause digestive upset like diarrhea or constipation. Some might experience lactose intolerance symptoms if sensitive. Allergic reactions are rare but possible.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a first-time hip or knee replacement surgery.
Select...
I am between 55 and 95 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had septic arthritis in the past.
Select...
My kidneys and liver are not in the final stages of failure.
Select...
I have a condition that prevents my body from absorbing proteins properly.
Select...
I am having or have had surgery to replace or fix a joint, but not a full knee replacement.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 2 (2 wks pre) visit 3 (surgery day) visit 5 (4 weeks post)
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 2 (2 wks pre) visit 3 (surgery day) visit 5 (4 weeks post) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in the patients' albumin, pre-albumin, and/or transferrin levels

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Nutritional supplementationExperimental Treatment1 Intervention
Given Ensure Max Protein Nutrition shake 2 weeks before surgery and continued 2 weeks after surgery.
Group II: No Nutritional supplementationActive Control1 Intervention
Treatment as usual
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ensure
2020
Completed Phase 2
~260

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,409 Previous Clinical Trials
855,216 Total Patients Enrolled
17 Trials studying Osteoarthritis
3,741 Patients Enrolled for Osteoarthritis
Ran SchwarzkopfPrincipal InvestigatorNYU Langone
1 Previous Clinical Trials
160 Total Patients Enrolled

Media Library

Ensure Clinical Trial Eligibility Overview. Trial Name: NCT04210284 — N/A
Osteoarthritis Research Study Groups: Nutritional supplementation, No Nutritional supplementation
Osteoarthritis Clinical Trial 2023: Ensure Highlights & Side Effects. Trial Name: NCT04210284 — N/A
Ensure 2023 Treatment Timeline for Medical Study. Trial Name: NCT04210284 — N/A
~55 spots leftby Jul 2025